7Baggers

EXAS Stock Cash Flow Statements

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
     Operating Cash Flow  
     Investing Cash Flow  
     Financing Cash Flow  
     Net Income  
    Quarterly
     | 
    Annual
     
    20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -834.77-575.59-316.42-57.24201.94461.12720.3979.48Milllion
    Quarterly Cash Flow Statements
    Quarterly
     | 
    Annual
     
      Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 2011-09-30 2011-06-30 2011-03-31 2010-09-30 2010-06-30 2010-03-31 2009-09-30 2009-06-30 2009-03-31 2008-03-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-09-30 2005-06-30 2005-03-31 2004-09-30 2004-06-30 2003-03-31 2002-03-31 2001-09-30 
                                                                       
        cash flows from operating activities:                                                               
        net income-49,766,000 794,000 -81,026,000 -74,151,000 -127,745,000 -148,761,000 -166,063,000 -180,937,000 -220,611,000 -166,938,000 -176,912,000 -31,164,000 -436,810,000 -219,884,000 -86,142,000 -105,697,000 77,945,000 -40,459,000 -38,420,000 -83,059,000 -53,974,000 -45,364,000 -44,765,000 -47,473,000 -39,991,000 -42,945,000 -39,066,000 -35,801,000 -32,444,000 -32,060,000 -19,437,000 -16,107,000 -11,160,000 -12,314,000 -10,854,000 -12,952,000 -14,836,000 -10,645,000 -7,773,000 -6,625,000 -4,373,000 -3,382,000 -2,477,000 -2,124,000 -1,041,000 -2,394,000 -3,839,000 -2,518,000 -4,195,000 -1,825,000 -1,920,000 -12,904,508 7,398,508 -3,246,000 -4,163,000 -3,289,000 -3,951,000 -4,585,000 -4,403,000 -9,562,117 -7,883 -7,585,885  
        adjustments to reconcile net income to net cash from operating activities:                                                               
        depreciation30,861,000 29,262,000 27,510,000 26,815,000 26,567,000 25,043,000                                               -298,612 101,000 198,000 162,000 226,000 210,000 276,000 634,531 469   
        (gain) loss on non-marketable and marketable equity investments                                                               
        deferred tax benefit-676,000    -2,555,000 -4,406,000 -3,028,000 -1,912,000 -4,453,000 -4,207,000 -1,379,000 -243,130,000 -1,886,000 -4,754,000 -1,304,000 -1,918,000    -520,000                                            
        stock-based compensation58,577,000 61,871,000 61,725,000 49,139,000 45,917,000 49,533,000 58,932,000 52,441,000 55,883,000 63,603,000 56,285,000 77,292,000 41,831,000 41,476,000 40,039,000 29,560,000 47,826,000 24,348,000 20,143,000 16,166,000 15,710,000 16,498,000 4,507,000 6,100,000 4,902,000 4,980,000 4,548,000 3,620,000 2,877,000 4,165,000 2,483,000 1,995,000 1,849,000 2,856,000 955,000 1,565,000 1,424,000 1,035,000 1,101,000 1,068,000 686,000 640,000 508,000 527,000 624,000 711,000 623,000 301,000 1,376,000 720,000 409,000 3,003,555 -1,774,555 710,000 1,067,000 -81,000     328   
        post-combination expense for acceleration of unvested equity        0 0 0 80,960,000                                                    
        gain on settlement of convertible notes                                                               
        amortization of acquired intangible assets23,311,000 22,992,000 22,929,000 22,928,000 22,914,000 23,526,000 26,356,000 24,654,000 24,047,000 23,940,000 23,824,000 23,190,000  23,430,000 23,430,000 23,339,000                                                
        asset acquisition ipr&d expense        0 0 33,074,000 52,263,000                                                    
        loss on sale of asset    0                                                           
        impairment of long-lived assets0 0 552,000 69,000 3,432,000                                                           
        gain on contingent consideration from sale of asset-4,400,000                                                               
        remeasurement of contingent consideration liabilities-4,993,000                                                               
        non-cash lease expense6,973,000 7,141,000 6,971,000 6,806,000 4,187,000 7,171,000 9,918,000 7,363,000 7,478,000 6,510,000 6,097,000 5,740,000 4,679,000 4,181,000 -3,330,000 10,190,000    845,000                                            
        other-3,131,000 -435,000                                                              
        changes in assets and liabilities, net of effects of acquisition:                                                               
        accounts receivable-3,110,000 -19,814,000 4,942,000 -25,434,000 33,120,000 -2,664,000 19,612,000 11,020,000 39,188,000 -23,033,000 31,945,000 -22,950,000 -26,884,000 -42,998,000 -24,322,000 -6,322,000    -11,856,000 -1,795,000 -5,648,000 -1,820,000 -688,000 -724,000 -2,058,000 -570,000 -205,000                                    
        inventory5,384,000 -543,000 -6,704,000 -5,827,000 -3,526,000 473,000 -2,214,000 -7,964,000 -8,130,000 -5,358,000 1,035,000 3,232,000 -11,838,000 1,788,000 -12,791,000 -7,469,000    -5,121,000 -139,000 -3,208,000 -247,000 -1,480,000 -645,000 243,000 -852,000 -1,406,000                                    
        operating lease liabilities-6,960,000 -6,975,000 -6,784,000 -5,982,000 -4,404,000 -5,574,000 -5,491,000 -5,177,000 -4,851,000 -4,739,000 -3,975,000 -3,120,000 -2,649,000 -1,138,000 -2,787,000 -2,210,000                                                
        accounts payable and accrued liabilities31,666,000 2,330,000 53,571,000 -4,817,000 37,088,000 -9,929,000 -13,291,000 -66,048,000 105,456,000 37,206,000 43,000,000 -15,862,000 62,773,000 39,979,000 -29,291,000 -18,296,000                                                
        other assets-7,932,000 5,938,000 3,998,000 -13,622,000                                                            
        other liabilities7,607,000 -5,508,000 5,395,000 -1,161,000                                                            
        net cash from operating activities69,549,000 24,361,000 100,424,000 -38,215,000 52,037,000 -40,926,000 -60,916,000 -173,754,000 -24,572,000 -40,774,000 40,337,000 -77,227,000 111,404,000 81,775,000 -6,870,000 -49,827,000 -28,684,000 -29,080,000 17,161,000 -74,407,000 -1,236,000 -4,053,000 -35,624,000 -42,347,000 -33,804,000 -34,525,000 -31,187,000 -34,501,000                                    
        cash flows from investing activities:                                                               
        purchases of marketable securities-64,758,000 -24,440,000 -42,067,000 -8,589,000 -29,048,000 -23,328,000 -8,843,000 -70,267,000 -142,493,000 -106,268,000 -752,791,000 -162,498,000 -199,941,000 -249,927,000 -214,917,000 -425,168,000 -29,988,000 -92,542,000 -248,700,000 -262,887,000 -110,844,000 -186,806,000 0 -6,118,000 -7,057,000 -178,679,000 -8,173,000 -11,145,000                                    
        maturities and sales of marketable securities35,102,000 57,229,000 149,493,000 121,332,000  108,130,000 118,680,000 150,630,000  99,450,000 89,085,000 236,295,000  291,424,000 229,340,000 39,143,000                                                
        purchases of property, plant and equipment-34,922,000 -25,187,000 -34,721,000 -29,360,000 -72,876,000 -44,637,000 -63,326,000 -33,623,000 -59,392,000 -38,870,000 -24,584,000 -12,920,000 -16,570,000 -14,327,000 -20,770,000 -12,685,000 -40,832,000 -51,522,000 -68,791,000 -10,657,000                                            
        proceeds from sale of asset    0                                                           
        maturities and sales of investments in privately held companies                                                               
        investments in privately held companies-10,274,000 -117,000 -5,731,000 -442,000  -160,000 -25,495,000 -1,172,000  -3,555,000 0 -10,000,000                                                    
        business combination, net of cash acquired and issuance costs    -15,371,000 0                                                          
        asset acquisitions, net of cash acquired                                                               
        other investing activities500,000 250,000   -500,000 0 -42,000 -7,000 -500,000 0 -103,000 -141,000 -137,000 272,000 -186,000 -330,000                                                
        net cash from investing activities-66,767,000 -32,969,000 66,474,000 82,941,000 -58,159,000 65,005,000 21,659,000 45,561,000 78,437,000 -49,243,000 -793,767,000 -317,512,000 -306,638,000 16,828,000 -6,380,000 -405,847,000 -834,774,000 857,442,000 -102,672,000 -41,069,000 -9,417,000 -78,988,000 31,298,000 53,173,000 40,956,000 -141,975,000 19,500,000 16,764,000    17,304,000   6,824,000             2,560,000 5,499,000 1,591,000 1,516,000 4,520,483 -7,721,483 6,104,000 1,622,000 2,773,000 11,919,000 2,130,000   2,568   
        cash flows from financing activities:                                                               
        proceeds from accounts receivable securitization facility    0 0                                                          
        proceeds from exercise of common stock options304,000 1,077,000 852,000 964,000 558,000 941,000 743,000 4,282,000 1,065,000 1,755,000 2,858,000 8,759,000 11,669,000 4,470,000 6,638,000 4,300,000 2,398,000 1,391,000 1,348,000 3,650,000 260,000 731,000 261,000 288,000 287,000 102,000 473,000 386,000 2,216,000 231,000 105,000 88,000                                
        payments on construction loan                                                               
        proceeds from issuance of convertible notes0 0 0 137,976,000         0 0 0 1,125,547,000 0 -2,000 -57,000 729,536,000 -1,000 6,000                                          
        other financing activities-2,267,000 -985,000 -1,155,000 -5,344,000 -417,000 -706,000 -2,860,000 -1,547,000 -544,000 -1,674,000 -1,554,000 -1,514,000 -2,067,000 -312,000 -313,000 -313,000                                                
        net cash from financing activities10,037,000 92,000 16,041,000 133,596,000 10,103,000 235,000 63,412,000 2,735,000 -12,196,000 81,000 13,342,000 7,245,000 879,859,000 4,158,000 16,124,000 979,480,000 6,624,000 980,000 5,451,000 240,126,000 9,354,000 19,074,000 1,267,000 247,000 2,509,000 174,166,000 4,795,000 295,000 105,865,000 136,000 138,025,000 2,000 636,000 73,616,000 8,000 57,981,000 222,000 1,642,000 331,000 211,000 14,000 1,434,000 17,743,000 1,109,000 804,000 8,071,000 22,614,000 6,000 117,000 0 15,000 472,881 -70,881 18,000 53,000 65,000 4,000 69,000 105,000 43,831,819 181 251,460  
        effects of exchange rate changes on cash and cash equivalents1,947,000 -1,235,000 59,000 550,000 3,206,000 -2,429,000 -510,000 -237,000            120,000 24,000 10,000                                          
        net increase in cash, cash equivalents and restricted cash14,766,000 -9,751,000 182,998,000 178,872,000     41,692,000 -89,936,000 -740,088,000 -387,494,000 684,625,000 102,761,000 2,874,000 523,806,000                                                
        cash, cash equivalents and restricted cash at the beginning of period                                                               
        cash, cash equivalents and restricted cash at the end of period                                                               
        unrealized loss on equity investments 5,523,000 7,090,000 3,009,000                                                            
        realized (gain) loss on non-marketable investment                                                               
        gain on settlements of convertible notes 0 0 -10,324,000                                                            
        changes in assets and liabilities:                                                               
        business combination, net of cash acquired        -84,181,000 0 -72,301,000 -343,248,000 0 -4,000 153,000 -6,807,000                                                
        sales of investments in privately held companies                                                               
        proceeds in connection with the company’s employee stock purchase plan 0    0    0    0                0                                  
        cash, cash equivalents and restricted cash, beginning of period 0 0 242,790,000  0 0 315,768,000  0 0 1,491,594,000  0 0 177,528,000                                                
        cash, cash equivalents and restricted cash, end of period -9,751,000 182,998,000 421,662,000  21,885,000 23,645,000 190,073,000  -89,936,000 -740,088,000 1,104,100,000  102,761,000 2,874,000 701,334,000                                                
        deferred tax expense  -589,000 1,261,000                                                            
        realized gain on non-marketable investment                                                               
        remeasurement of contingent consideration  4,250,000 -8,937,000 1,002,000 -5,860,000 -25,079,000 -26,680,000 -4,626,000 1,785,000 6,322,000 2,879,000                                                    
        loss on disposal of property, plant and equipment   284,000 -220,000 1,917,000 -155,000 321,000 127,000 289,000 302,000 337,000 1,540,000 280,000 378,000 272,000 514,000 669,000 129,000 82,000                                            
        amortization of deferred financing costs, convertible note debt discount and issuance costs, and other liabilities   1,783,000 1,854,000 1,853,000 1,720,000 1,700,000 1,735,000 1,666,000 1,649,000 1,633,000                                                    
        accretion (amortization) of discount (premium) on short-term investments   -54,000                                                            
        unrealized (gain) loss on equity investments      2,897,000 1,350,000 -445,000                                                       
        realized (gain) loss on non-marketable investments                                                               
        loss on settlement of convertible notes            0 0 0 7,954,000    10,558,000                                            
        amortization of premium on short-term investments    50,000 302,000 537,000 956,000  1,649,000 1,177,000 439,000  537,000 450,000 53,000 -213,000 -309,000 -1,274,000 -1,306,000 -1,320,000 -1,189,000 132,000 214,000 303,000 318,000 325,000 377,000 214,000 258,000 225,000 145,000 188,000 130,000 140,000                             
        other assets and liabilities    6,079,000 -1,990,000 2,337,000 -7,834,000 -37,801,000 -20,040,000 -1,127,000 1,033,000 6,767,000 -8,460,000 52,857,000 -9,438,000                                                
        investment in privately held companies                                                               
        payments on settlement of convertible notes            0 0 0 -150,054,000    -493,355,000                                            
        realized (gain) loss on preferred stock investment                                                               
        asset acquisition         0 -33,073,000 -25,000,000                                                    
        net decrease in cash, cash equivalents and restricted cash     21,885,000 23,645,000 -125,695,000                                                        
        realized gain on preferred stock investment        0 0 0 -30,500,000                                                    
        intangible asset impairment charge        0    0                                                   
        depreciation and amortization       22,993,000 21,078,000 22,260,000 21,499,000 20,508,000  19,713,000 17,626,000 16,006,000                             18,000                 449,494  
        unrealized gain on equity investments          -2,479,000 -7,000                                                    
        depreciation and other amortization                                                               
        unrealized net (gain) loss on revaluation of equity securities                                                               
        loss on preferred stock investment                                                               
        amortization of acquired intangibles                                                               
        asset acquisition, net of cash acquired                                                               
        proceeds from construction loan, net deferred financing costs                                                               
        realized gain on sale of marketable securities                                                               
        unrealized net income on revaluation of equity securities                                                               
        purchases of intangible assets                                                               
        proceeds from financing obligation, net payments on mortgage payable                                                               
        stock issuance costs                                                               
        ​                                                               
        supplemental disclosure of non-cash investing and financing activities:                                                               
        issuance of 86,532 and 86,882 shares of common stock to fund the company’s 401(k) matching contribution for 2018 and 2017, respectively                 0                                              
        issuance of 2,159,017 shares of common stock upon settlement of convertible notes                                                               
        issuance of 2,158,991 shares of common stock upon settlement of convertible notes                  0 182,435,000                                            
        issuance of 86,532 and 86,828 shares of common stock to fund the company’s 401(k) matching contribution for 2018 and 2017, respectively                   7,409,000                                            
        proceeds from refundable tax credits                                                               
        business acquisition, net of cash acquired                                                               
        investment in privately-held company                                                               
        payments on capital lease                                                               
        property acquired under build-to-suit lease                                                               
        issuance of 86,882, 158,717, and 341,507 shares of common stock to fund the company’s 401(k) matching contribution for 2017, 2016, and 2015, respectively                                                               
        business acquisition contingent consideration liability                                                               
        issuance of 86,882 and 158,717 shares of common stock to fund the company’s 401(k) matching contribution for 2017 and 2016, respectively                     0                                          
        issuance of 340,950 and 21,826 shares of common stock to fund the company’s 401(k) matching contribution for 2015 and 2014, respectively                      5,000 2,146,000                                        
        proceeds from new market tax credit financing agreements                                                               
        issuance of 21,826, 32,666 and 30,538 shares of common stock to fund the company’s 401(k) matching contribution for 2014, 2013 and 2012, respectively                                                               
        issuance of 21,826 and 32,669 shares of common stock to fund the company’s 401(k) matching contribution for 2014 and 2013, respectively                         0                                      
        issuance of 21,826 and 32,666 shares of common stock to fund the company’s 401(k) matching contribution for 2014 and 2013, respectively                           835,000                                    
        issuance of 32,666, 30,538, and 32,872 shares of common stock to fund the company’s 401(k) matching contribution for 2013, 2012, and 2011, respectively                                                               
        laboratory equipment acquired with a capital lease                                                               
        issuance of 32,269 and 30,534 shares of common stock to fund the company’s 401(k) matching contribution for 2013 and 2012, respectively                                                               
        issuance of 32,266 and 30,534 shares of common stock to fund the company’s 401(k) matching contribution for 2013 and 2012, respectively                                                               
        issuance of 32,666 and 30,534 shares of common stock to fund the company’s 401(k) matching contribution for 2013 and 2012, respectively                               456,000                                
        issuance of 30,534 and 32,872 shares of common stock to fund the company’s 401(k) matching contribution for 2012 and 2011, respectively                                0                               
        conversion of accrued expenses into 34,442 and 34,336 shares of common stock in connection with the company’s employee stock purchase plan for 2013 and 2012, respectively.                                0                               
        net decrease in cash and cash equivalents                                                               
        issuance of 30,534 and 32,872 shares of common stock to fund the                                                               
        issuance of 32,872 and 27,872 shares of common stock to fund the company’s 401(k) matching contribution for 2011 and 2010, respectively                                   0 0 274,000                          
        conversion of accrued expenses into 34,336 and 27,110 shares of common stock in connection with the company’s employee stock purchase plan for 2012 and 2011, respectively                                   0                            
        decrease in restricted cash                                                               
        issuance of 27,872 and 15,460 shares of common stock to fund the company’s 401(k) matching contribution for 2010 and 2009, respectively                                      0 1,000 168,000                       
        issuance of 15,460 and 24,430 shares of common stock to fund the company’s 401(k) matching contribution for 2009 and 2008, respectively                                                               
        issuance of 15,460 and 24,430 shares of common stock to fund the company’s 401(k) matching contribution for 2009 and 2008 respectively                                                               
        issuance of 15,460 shares of common stock to fund the company’s 401(k) matching contribution for 2009                                           65,000                    
        amortization of deferred revenue                                                               
        payment to repurchase stock options                                                               
        supplemental disclosure for non-cash investing and financing activities:                                                               
        issuance of 24,430 shares of common stock to fund the company’s 401(k) matching contribution for 2008                                                               
        issuance of 27,660 shares of common stock to fund the company’s 401(k) matching contribution for 2007                                                               
        proceeds from sale of fixed assets                                                               
        issuance of 34,030 shares of common stock to fund the company’s 401(k) matching contribution for 2006                                                0               
        issuance of 56,675 shares of restricted common stock to collaborator in lieu of cash to settle semi-annual license obligation                                                0 0 158,000             
        issuance of 56,675 shares of restricted common stock to collaborators in lieu of cash payments                                                               
        issuance of 85,800 shares of common stock to fund the company’s 401(k) matching contribution for 2005                                                   183,816            
        cash and cash equivalents, beginning of year                                                               
        cash and cash equivalents, end of year                                                               
        supplemental disclosure of non-cash financing activities:                                                               
        adjustments to reconcile net income to net cash from operating activities –                                                               
        amortization of deferred licensing fees                                                               
        prepaid expenses                                                               
        deferred license fees                                                               
        purchase of marketable securities                                                               
        adjustments to reconcile net income to net cash from operating activities                                                               
        purchase of treasury shares                                                               
        adjustments to reconcile net income to net cash from operating activities–                                                               
        depreciation and amortization expense                                                               
        amortization of licensing fees                                                               
        non-cash expense associated with issuance of warrants                                                               
        interest receivable                                                               
        net proceeds from sale of preferred stock                                                               
        proceeds from exercise of common stock options and purchase plans                                                               
        issuance of warrants to purchase common stock                                                               
        purchase of treasury shares through the forgiveness of notes                                                               
        equipment purchased through capital lease obligations                                                               
        adjustments to reconcile net income to net cash from operating activities—                                                               
        repurchase of treasury shares                                                               
        adjustments to reconcile net income to net cash from operating activities-                                                               
        payments on capital lease bligations                                                               
        net proceeds from sale of convertible preferred stock